全文获取类型
收费全文 | 18780篇 |
免费 | 1496篇 |
国内免费 | 470篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 595篇 |
妇产科学 | 166篇 |
基础医学 | 1416篇 |
口腔科学 | 313篇 |
临床医学 | 1435篇 |
内科学 | 1798篇 |
皮肤病学 | 272篇 |
神经病学 | 1420篇 |
特种医学 | 585篇 |
外国民族医学 | 5篇 |
外科学 | 1020篇 |
综合类 | 2269篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 2275篇 |
眼科学 | 316篇 |
药学 | 4137篇 |
24篇 | |
中国医学 | 1288篇 |
肿瘤学 | 1299篇 |
出版年
2023年 | 255篇 |
2022年 | 301篇 |
2021年 | 535篇 |
2020年 | 617篇 |
2019年 | 538篇 |
2018年 | 549篇 |
2017年 | 663篇 |
2016年 | 688篇 |
2015年 | 618篇 |
2014年 | 1197篇 |
2013年 | 1601篇 |
2012年 | 1000篇 |
2011年 | 1036篇 |
2010年 | 800篇 |
2009年 | 827篇 |
2008年 | 854篇 |
2007年 | 862篇 |
2006年 | 743篇 |
2005年 | 682篇 |
2004年 | 579篇 |
2003年 | 556篇 |
2002年 | 419篇 |
2001年 | 349篇 |
2000年 | 299篇 |
1999年 | 257篇 |
1998年 | 272篇 |
1997年 | 264篇 |
1996年 | 194篇 |
1995年 | 198篇 |
1994年 | 205篇 |
1993年 | 186篇 |
1992年 | 207篇 |
1991年 | 199篇 |
1990年 | 182篇 |
1989年 | 170篇 |
1988年 | 177篇 |
1987年 | 178篇 |
1986年 | 158篇 |
1985年 | 174篇 |
1984年 | 188篇 |
1983年 | 105篇 |
1982年 | 151篇 |
1981年 | 106篇 |
1980年 | 110篇 |
1979年 | 98篇 |
1978年 | 72篇 |
1977年 | 72篇 |
1976年 | 63篇 |
1975年 | 47篇 |
1974年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 82 毫秒
41.
Inter-study differences: How should they influence the interpretation and analysis of results? 总被引:2,自引:0,他引:2
K R Bailey 《Statistics in medicine》1987,6(3):351-360
In determining the role inter-study variation should play in an overview analysis, it is important to consider three factors: which question one is trying to answer; the degree of similarity or dissimilarity of design, and the degree to which heterogeneity of outcomes can be explained. Three questions one might be interested in are: whether treatment can be effective in some circumstances; whether treatment is effective on average, and whether treatment was effective on average in the trials at hand. Under the assumption of no qualitative interaction, the answers to these questions coincide. The O-E analysis most directly answers the third question. Other analyses are suggested when the first question is of interest, using the aspirin post-MI studies as an example. 相似文献
42.
Summary The aim of this study was to investigate imipramine-induced alterations of cytochrome P-450 and to determine whether prolonged concomitant administration of imipramine and lithium results in a pharmacokinetic interaction.Male Wistar rats received imipramine (10 mg/kg i. p.) at 12 h intervals or lithium chloride (100 mg/kg in drinking water) or they were treated with the combination of these drugs for 2 weeks. The long term treatment with imipramine produced a very complex alteration of cytochrome P-450: imipramine increased the level of the cytochrome, but it decreased the rate of its own aromatic hydroxylation in position 2. The rate of N-demethylation in the side chain was not changed. Consequently, in the case of both hydroxylation and demethylation, calculated molecular activities were decreased to 48% and 70% respectively. This differential change in activities corresponded well to the observed decrease of absorption in difference spectra (type I) produced in microsomes by imipramine. Carbamazepine-induced type I difference spectra were also decreased by imipramine pretreatment, but to a lesser extent. In contrast, hexobarbital type I binding was increased by imipramine treatment while type II difference spectra produced by metyrapone were not affected. The preliminary SDS-PAGE analysis of cytochrome P-450 isoenzymes of control and imipramine treated rats showed that the investigated antidepressant markedly intensified a protein band at 50.11 kD while bands at 51.28 kD, 56.20 kD and 56.88 kD were less intensive. These results indicate that the alteration of cytochrome P-450 by imipramine treatment is not only of quantitative but also of qualitative character. Lithium alone given to rats affected neither the concentration of cytochrome P-450 in microsomal protein nor the rate of imipramine metabolism in vitro. Lithium given jointly with imipramine reduced imipramine-induced elevation of cytochrome P-450. This, however, did not cause any change in the rate of imipramine metabolism in vitro and accordingly in imipramine pharmacokinetics in vivo. The concentration of lithium in the blood plasma tended to increase by concurrent administration of imipramine.Send offprint requests to K. J. Netter at the above address 相似文献
43.
观察了黄芪注射液对流行性出血热病毒(EHF.V)的抑制作用。动物及传代细胞实验结果显示:黄芪注射液对小白鼠乳鼠体内EHF.V的感染过程具有一定的阻断作用;其机制可能主要是通过宿主的免疫调节而发挥作用。 相似文献
44.
M S al-Humayyd 《Biopharmaceutics & drug disposition》1990,11(5):411-417
The effect of diltiazem on the plasma level of carbamazepine (CBZ) was investigated in rabbits. The animals were given either CBZ alone or in combination with diltiazem and plasma samples were collected at different time intervals. The concentration of CBZ was detected using an HPLC method. Diltiazem significantly increased the area under the curve (AUC), the maximum plasma concentration (Cmax), and the elimination half-life (t1/2) of CBZ (p less than 0.05). These results suggest that a potentially harmful drug-drug interaction may occur if CBZ and diltiazem are administered concurrently. 相似文献
45.
Clinical Efficacy of New Antiepileptic Drugs in Refractory Partial Epilepsy: Experience in the United States With Three Novel Drugs 总被引:1,自引:1,他引:0
Jacqueline A. French 《Epilepsia》1996,37(S2):S23-S26
Summary: A number of new antiepileptic drugs (AEDs), including topiramate (TPM), felbamate (FBM), and gabapentin (GBP), are approved or believed to be close to approval for marketing in the United States. Key efficacy findings for these AEDs in refractory partial epilepsy were reviewed. Large and significant drug-placebo differences were observed with TPM in two large dose-finding trials conducted in the United States. The minimal effective dose of TPM in the population studied was determined to be approximately 200 mg/day, and doses above 600 mg/day produced good efficacy but little incremental benefit versus the lower dosages for the overall study population. FBM is active in partial epilepsy, although seizure reduction is less marked and drug interactions complicate the findings. GBP is also active in this population, but only the 1,800 mg/day dosage was significantly better than placebo with respect to percent re-sponders. It may be useful to explore higher dosage ranges for both FBM and GBP if they can be well tolerated. 相似文献
46.
3-Methoxytyramine (3-MT) is a minor metabolite of dopamine which is suggested to reflect the turnover and utilization of dopamine. A novel, isocratic HPLC method has been developed which can be used to analyse 3-MT in homogenates of rat brain without the need for additional purification procedures. Furthermore, the coulometric electrochemical detection system is sensitive enough to measure 3 pg of 3-MT (equivalent to 0.6 ng/g tissue wet weight). 3-Methoxytyramine was measured in the striatum and n. accumbens after decapitation and rapid freezing, using 3-methoxy-4-hydroxybenzylamine as the internal standard. The effects of dopaminergic and other drugs on this metabolite were examined using this method. -Methyl-p-tyrosine (200 mg/kg i.v.) produced parallel linear decreases in dopamine and 3-MT in naive rats, but not those pretreated with tranylcypromine (5 mg/kg i.p.). Methamphetamine (0.3–10 mg/kg i.p.) and amphetamine (0.3–10 mg/kg i.p.) both dose-dependently increased 3-MT in naive and tranylcypromine-pretreated rats. In naive animals, 3-MT was not altered by intraperitoneal injection of the dopamine reuptake inhibitors, bupropion (10 mg/kg) and nomifensine (10 mg/kg) or by sibutramine HCl (3 mg/kg), amitriptyline (10 mg/kg), desipramine (10 mg/kg) and zimeldine (10 mg/kg). 3-Methoxy-tyramine was decreased by apomorphine (5 mg/kg i.p.) and also by large doses of the selective D2 antagonist, BRL 34778 (5 mg/kg i.p.) or
-DOPA (50 mg/kg i.p.). The selective D1 antagonist, SCH 23390 (0.1 or 5 mg/kg i.p.) was without effect. In tranylcypromine-pretreated rats, 3-MT was dose-dependently reduced and increased by apomorphine (0.01–5 mg/kg i.p.) and BRL 34778 (0.1–5 mg/kg i.p.), respectively. The drug SCH 23390 (0.1–5 mg/kg i.p.) produced much smaller increases in 3-MT which were probably mediated through the striatonigral pathway. Overall, the data suggest that measurement of 3-MT, after inhibition of monoamine oxidase, is a useful index of the release and utilization of dopamine. However, after substantial and prolonged depletion of dopamine, levels of 3-MT in naive animals are a better index. Also, the formation of 3-MT in naive rats provides a sensitive method for distinguishing between dopamine releasing agents and reuptake inhibitors. 相似文献
47.
Within a number of physiological preparations, the effects of alcohol and cocaine in combination are reported to be greater
than the effects of either drug given alone. Little has been reported, however, on the behavioral effects of the interaction.
The present study investigated this issue by assessing the effects of cocaine and alcohol (alone and in combination) on schedule-controlled
responding. Specifically, rats were trained to respond on an FR20 schedule for a water reinforcer. They were then administered
cumulative doses of cocaine or alcohol. Following this, subjects were administered ineffective doses of alcohol prior to further
dose-response assessments with cocaine and with ineffective doses of cocaine prior to further dose-response assessments with
alcohol. Cocaine and alcohol alone produced dose-related decreases in responding. Furthermore, the dose-response function
for cocaine was shifted to the left by alcohol and the dose-response function for alcohol was shifted to the left by cocaine.
An isobolographic analysis revealed that the interaction between cocaine and alcohol was additive in nature. The possible
bases for the interaction (e.g., changes in cocaine pharmacokinetics by alcohol and the formation of cocaethylene following
co-administration of cocaine and alcohol) were discussed.
Received: 22 February 1996 / Final version: 23 August 1996 相似文献
48.
The pharmacokinetics and haemodynamic effects of isosorbide dinitrate (ISDN) have been investigated following administration of single doses as a sublingual (SL) spray (2.5 mg), sublingual tablet (5 mg) and peroral tablet (10 mg) in a randomised, placebo-controlled double-blind cross-over trial in 16 healthy volunteers.After the sublingual spray Cmax was higher (39.0 ng·ml-1) and tmax was shorter (3.9 min) than after the sublingual (22.8 ng·ml-1 and 13.8 min) and peroral (16.9 ng·ml-1 and 25.6 min) tablets. The AUC of ISDN did not differ following any of the three formulations (1031; 879; 997 ng·ml-1·min, for the spray, SL tablet and PO-tablet, respectively). Mononitrate metabolites of ISDN (IS-2-MN and IS-5-MN) and total nitrates in plasma increased in proportion to the administered dose. This indicates that the fraction of the dose absorbed was the same for all the formulations but that the extent of first-pass metabolism increased in the order sublingual spray < sublingual tablet < peroral tablet. Thus, compared to the spray, the relative bioavailability of ISDN was 48% and 28% from the sublingual and peroral tablets, respectively.The haemodynamic effects were quantified using the a/b ratio of the finger pulse wave and the systolic blood pressure and heart rate under orthostatic conditions. For the a/b ratio of the finger pulse, the maximal effect was higher (emax=130%) and the time to emax (temax) shorter (16.6 min) after the spray than the sublingual tablet (84.4% and 25.5 min) or peroral tablet (90.2 and 31.3 min). The onset of effect was within 3, 5 and 7.5 min after the spray, sublingual and peroral tablets, respectively. A larger change in the orthostatically-induced decrease in systolic blood pressure and increase in heart rate was obtained following peroral than sublingual administration despite the similar plasma concentrations of ISDN. This probably reflects the larger amount of pharmacodynamically active mononitrate metabolites formed after oral dosing. The integrated effect following administration of 2.5 mg ISDN as spray was similar to that of a sublingual tablet of 5 mg. 相似文献
49.
T Kyrklund 《American journal of industrial medicine》1992,21(1):15-24
The nervous system differs from many other body organs by its central control of vital functions and its low regeneration capacity. Organic solvents have, as a group, been suspected to have neurotoxic effects. Because of their similar physical properties and the fact that in industrial uses, they are often present in various mixtures, organic solvents have also been regarded, unfortunately, to induce common neurotoxic effects. However, it is evident from experimental studies using specified exposure conditions that different organic solvents have very diverse neurotoxic effects and also that the toxic mechanism may differ between acute and chronic exposure. No specific method used to describe a neurotoxic effect or single toxic response can be used for the overall occupational risk assessment of all organic solvents. Each solvent has to be considered as having its own unique toxic effects. 相似文献
50.